show episodes
 
Editors at The Lancet Microbe, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to this open access journal, this podcast covers a broad range of topics, from using probiotics to reduce Staphylococcus aureus, to phage therapy and monitoring antimicrobial resistance using faecal metagenomes, and more.
  continue reading
 
The Phage Therapy Today is the pod dedicated to leaders in the phage therapy industry. We bring you insights into current advancements and challenges in this exciting sector from academia, financial, regulatory, manufacturing and entrepreneurial perspectives. Each episode features accomplished guests serving various roles in developing our bacteriophage-evolved community. If you are a believer in the future shaped by phage therapy and want to share you exciting work with our community, email ...
  continue reading
 
Artwork

1
Communicable

CMI Communications

Unsubscribe
Unsubscribe
Monthly
 
Communicable takes on hot topics in infectious diseases and clinical microbiology. Hosted by the editors of CMI Communications, the open-access journal of ESCMID, the European Society of Clinical Microbiology & Infectious Diseases.
  continue reading
 
Artwork

1
Editors in Conversation

American Society for Microbiology

Unsubscribe
Unsubscribe
Monthly
 
Editors in Conversation is the official podcast of the American Society for Microbiology Journals. Editors in Conversation features discussions between ASM Journals Editors, researchers and clinicians working on the most cutting edge issues in the microbial sciences. Topics include laboratory diagnosis and clinical treatment of infectious diseases, antimicrobial resistance, epidemiology of infections, multidrug-resistant organisms, pharmacology of antimicrobial agents, susceptibility testing ...
  continue reading
 
Artwork

1
Everybody Hates Me: Let's Talk About Stigma

Dr. Carmen Logie, Canada Research Chair

Unsubscribe
Unsubscribe
Monthly
 
Hosted by Dr. Carmen Logie, Canada Research Chair in Global Health Equity & Social Justice with Marginalized Populations, and Professor at the University of Toronto's Factor-Inwentash Faculty of Social Work. Supported by the Canada Foundation for Innovation (CFI). This podcast invites a range of weekly guests to talk about all different kinds of stigma. Why does it matter? What does it look like? What can we do about it?Thank you for listening! Follow us on Twitter (@let_stigma) and Instagra ...
  continue reading
 
Artwork
 
ARMOR on the Air is a student-led podcast based out of the University of Colorado Boulder. We discuss the antimicrobial resistance crisis and what we as members of the public can do to help! Join our hosts, undergraduates Ezra and Andy, as we learn more about superbugs and how to stop them! ARMOR is an outreach organization at CU Boulder. We promote safe and responsible use of antibiotics, support research into new antibiotics, and encourage the public to take steps in their daily lives to l ...
  continue reading
 
Loading …
show series
 
In this episode, hosts Josh Davis (Newcastle, Australia) and Angela Huttner (Geneva, Switzerland) interview the phage ‘microbiologist-clinician duo’, Drs. Shawna McCallin and Lorenz Leitner (Balgrist Hospital, Zurich, Switzerland). They explore the history of phages, the process of bringing phage therapy to a patient, potential resistance to phages…
  continue reading
 
What are WHO's most wanted bacterial pathogens in 2024? Hosts Angela Huttner & Oana Sandulescu welcome guests Dr. Hatim Sati of the World Health Organisation (WHO) and Dr. Erin Duffy (CARB-X) to discuss WHO’s new Priority Pathogens List. Developed by WHO and a panel of global experts, the List identifies the ‘top’ bacteria for which research & deve…
  continue reading
 
Antimicrobial resistance is a priority public health problem with complex roots and connotations. However, due to a lack of focus on this topic, research training programs, specifically those focused on AMR are limited. Additionally, scientific meetings that particularly highlight the science of antimicrobial resistance are scarce. We recently publ…
  continue reading
 
Elena Dalla Vecchia of The Lancet Microbe speaks to Edwin Armitage, Saffiatou Darboe, and Lamin Jaiteh about Streptococcus pyogenes carriage and transmission in households in The Gambia. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00046-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue thi…
  continue reading
 
CMI Communications editors Angela Huttner, Marc Bonten, and Erin McCreary discuss late-breaker clinical trials presented at ESCMID Global (ECCMID) in Barcelona, providing insights into the trials’ designs, results, and implications. The DOTS trial compared two doses of long-acting dalbavancin to standard of care in patients with complicated S. aure…
  continue reading
 
Rhodococcus infections are uncommon, however they can cause serious disease in certain patients. There are a number of challenges though when dealing with Rhodococcus infections, including the fact that much of what we know around their susceptibility profiles and the clinical management of infected individuals actually comes from a number case ser…
  continue reading
 
Phage therapy has gained a lot of traction but the challenges created by this approach have not been properly assessed at a big scale. We often read about therapy successes on isolated cases but, rarely, we read or hear about failures. AAC recently published a case series of patients who failed phage therapy. Today, we will discuss this topic with …
  continue reading
 
Rebecca Barksby of The Lancet Microbe speaks with Professor Martin Hoenigl about the impact of climate change and natural disasters on fungal diseases. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00039-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us…
  continue reading
 
Rebecca Barksby of The Lancet Microbe speaks to Dr Nancy Chow about sporotrichosis and discusses a genomic epidemiology study of this zoonotic fungal disease among people and cats in Brazil. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00364-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue…
  continue reading
 
The protozoan Lophomonas has been reported to be a pathogen of humans in a large number of case reports and case series. Most of these case reports describe infections of the respiratory tract. Editors in Conversation is joined by two experts to discuss this possible parasite. Some of the questions addressed include: What are the characteristics of…
  continue reading
 
Elena Dalla Vecchia of The Lancet Microbe speaks to Deborah Williamson and Michael Moso about non-SARS-CoV-2 respiratory viral detection from COVID-19 rapid antigen test devices. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00375-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conver…
  continue reading
 
Tuberculosis is one of the most deadly infectious diseases that still causes significant burden of disease, particularly in the developing world. The emergence of resistance to first line agents severely limits the therapeutic options and threaten the ability to control dissemination of this disease. Fortunately, new drugs and regimens are now emer…
  continue reading
 
A new generation of B-lactamase inhibitors is likely to reach the market in the upcoming year. These broad-spectrum inhibitors exhibit activity against the most feared class B metallo-B-lactamases maintaining the inhibition of other enzymes. Recently AAC has published three papers that describe the mechanistic bases of taniborbactam resistance amon…
  continue reading
 
We managed to make it through 2023 without a major epidemic or pandemic, and as we get into the holiday spirit and look forward to the new year, some of us took a look back and picked out one of our favorite JCM paper published in 2023, which I will tell you, was no easy task as there were many of good ones to choose from! And personally, after loo…
  continue reading
 
Welcome back to Phage Therapy Today! As phage therapy is becoming global, so are funding opportunities. In this week's episode, our guests, Dr. Mercedes Gonzalez from Incubator for Antibacterial Therapies in Europe (INCATE) and Dr. Gregorio Iraola, at Kinzbio sat down with us to talk about these funding opportunities and how startup companies can b…
  continue reading
 
Gonorrhea remains one of the more common sexually transmitted infections. In North America, the number of reported cases has generally risen for over ten years, with interruptions in the early days of the COVID-19 pandemic, followed by returns to rising rates of infection. Under the selective pressure of antimicrobial treatment, antimicrobial resis…
  continue reading
 
Rebecca Barksby of The Lancet Microbe speaks to Professor Kate Baker about the challenges, potential, and recommendations for using genomics to monitor antimicrobial resistance. Read the full Series: https://www.thelancet.com/series/amr-genomics?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... …
  continue reading
 
In the last few years we have witnessed the rise of very resistant fungal species some of them likely influenced by environmental conditions and climate change. Fortunately, there has been a bit of an explosion in the development of new antifungals and the pipeline has been strengthened in the last decade. We will have the ability to have new molec…
  continue reading
 
Despite the many advances in diagnostic testing for infectious diseases, detection of Coccidoides infections continues to rely on serologic assessment for anti-fungal antibodies, and what is perhaps more astonishing is that the serologic methods we use today, such as complement fixation and immunodiffusion, were first developed about a century ago.…
  continue reading
 
In this episode, learn more about current applications of phage therapy, an alternative to antibiotics! We're here to give an update of bacteriophages (viruses that infect bacteria) and the current state of affairs in research and clinical applications. Listen in to learn a little about how bacteriophages are being modified to treat bacterial infec…
  continue reading
 
Climate change is possibly the major threat that planet earth is experiencing in this century with potential catastrophic consequences. As the planet warms, the change in weather patterns is affecting the microbial ecology in such a manner that humans are facing new health threats including emerging diseases and facing species of organisms that are…
  continue reading
 
Fungi that are resistant to antifungal drugs have been very much in the news and even the subject of the hugely popular television program, The Last of Us. We talk with two experts in mycology and fungal susceptibility testing about the recent descriptions of terbinafine-resistant dermatophytes in the United States. Some of the questions we will ad…
  continue reading
 
Artificial intelligence (AI) has the potential to change the way we practice medicine and public health. The tools and AI approaches can substantially impact a broad range of fields from the manner we approach patient care to strategies to discover new antimicrobials, track pandemics and deploy public health measures. AAC recently published a comme…
  continue reading
 
Dr. Angela Kaida is a Simon Fraser University Distinguished Professor and the Scientific Director of the Canadian Institutes of Health Research (CIHR) Institute for Gender and Health. Dr. Kaida’s research interests pertain to understanding the impact of expanding access to HIV treatment and prevention services on sexual and reproductive intentions,…
  continue reading
 
In this episode, learn about an alternative to antibiotics: phage therapy! We're here to give an overview of bacteriophages (viruses that infect bacteria) and the complex history of phage therapy. Listen in to learn a little about how bacteriophages can be used to treat bacterial infections in humans and why phage therapy isn't mainstream in the US…
  continue reading
 
Dr. Elli Theel and Dr. Alex McAdam discuss recent viral outbreaks with expert virologists. Recorded before a live audience at ASM Microbe 2023. Topics: What are the recent epidemiologic and diagnostic findings with Mpox? What are the reservoirs for influenza A H5N1 and how is it transmitted to humans? Why was there such a large number of cases of h…
  continue reading
 
In response to the global burden of antimicrobial resistance (AMR) and the critical role antimicrobial stewardship plays in optimizing antibiotic use and reducing the subsequent emergence of AMR, Antimicrobial Agents and Chemotherapy is excited to add a new section to the journal focused on antimicrobial stewardship studies. Combatting the devastat…
  continue reading
 
Rebecca Barksby of The Lancet Microbe talks to Dr Erica Furhmeister about monitoring antimicrobial resistance using faecal metagenomes. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00137-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... htt…
  continue reading
 
The combination of aztreonam with ceftazidime-avibactam is increasingly used for treatment of antimicrobial-resistant Gram-negative bacilli. Clinical laboratories are asked to perform susceptibility testing using this combination, but many laboratory directors have been unsure how to approach this. Today, we’ll discuss a recent paper in the Journal…
  continue reading
 
Recorded at ASM Microbe 2023, Cesar has a conversation with Dr. Maria Elena Bottazzi about the role of minority women in science and discovery, the journey of Hispanic women in science and the current challenges posed by society to deliver science and global health equity. Guest: Dr. Maria Elena Bottazzi - Sr. Associate Dean of the National School …
  continue reading
 
Kim Canady is an HIV/AIDS activist, advocate, mother, and wife born with HIV. Throughout her adolescence, Kimberly became a member of many HIV/AIDS awareness organizations. These organizations include Theo, Heat, UNICEF, YWCHAC, co-chair of YACAC, spokesmodel for New York State Department of Health campaign HIVSTOPSWITHME, and Love Heals. As an Afr…
  continue reading
 
Standardizing the phage therapy industry through processes like clinical trails is the way to go . One of the fundamental steps to broader use of phage therapy and successful therapy is producing phages following Good Manufacturing Practices (GMP) and JAFRAL is the leader in this field. In today's show we sit down with JAFRAL's founder and CEO Dr. …
  continue reading
 
Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Jie Zhou and Dr Anika Singanayagam about their SARS-CoV-2 human challenge study. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00101-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... htt…
  continue reading
 
Loading …

Quick Reference Guide